Monthly Archives: September 2015

VPR Brands, LP Announces Official Name Change and New Stock Symbol OTC: VPRB

MIAMI, FL / ACCESSWIRE / September 21, 2015 / VPR Brands, LP. (OTC PINK: VPRB), formerly known as Soleil Capital, LP, has completed its name change, along with the new stock symbol replacing JOBI. Effective today, VPR Brands, LP received approval from FINRA for a change of its name and symbol effective with the OTC market. The Company will be listed as “VPR Brands, LP.” with a new trading symbol of “VPRB” The new name and stock symbol now reflect the new Corporate Brand of the business.

CEO of VPR Brands, LP. Kevin Frija said, “We are pleased to take this next step in moving our company forward. These changes should clearly signal to the marketplace that this is a new company focused on new product lines and strategy.”

VPR BRANDS, LP. (OTC PINK: VPRB) is a technology holding company, whose assets include issued U.S. and Chinese patents for atomization related products including technology for medical marijuana vaporizers and electronic cigarette products and components. The company is also engaged in product development for the vapor or vaping market, including e-liquids. Electronic cigarettes (also known as ecigs or e-cigs) are electronic devices which deliver nicotine through atomization, or vaping of e-liquids and without smoke and other chemicals constituents typically found in traditional tobacco burning cigarette products.

Safe Harbor Disclaimer

This news release contains statements that involve expectations, plans or intentions and other factors discussed from time to time in the Company’s Securities and Exchange Commission filings. These statements are forward-looking and are subject to risks and uncertainties, so actual results may vary materially. You can identify these forward-looking statements by words such as “may,” “should,” “expect,” “anticipate,” “believe,” “estimate,” “intend,” “plan” and other similar expressions. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of certain factors not within the control of the company. The company cautions readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. The company disclaims any obligation subsequently to revise any forward-looking statements to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.

Contact Info

4401 NW 167th Street
Miami, FL 33055

SOURCE: VPR Brands, LP

ReleaseID: 432104

SeeThruEquity Issues Update on DelMar Pharmaceuticals Highlighting Recent Funding

NEW YORK, NY / ACCESSWIRE / September 21, 2015 / SeeThruEquity, a leading New York City based independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced that it has issued an update note on DelMar Pharmaceuticals, Inc. (OTCQX: DMPI), a biotechnology company focused on proven cancer therapies in new orphan drug indications where patients are failing modern targeted or biologic treatments.

The note is available here: DMPI September 2015 Update. SeeThruEquity is an approved equity research contributor on Thomson First Call, Capital IQ, FactSet, and Zack’s. The report will be available on these platforms. The firm also contributes its estimates to Thomson Estimates, the leading estimates platform on Wall Street.

“The raise included existing investors and new investors, consisting of 4.3mn common shares priced at $0.60, which we estimate increases the company’s total shares outstanding to 43.7mn. Additionally, the placement has the potential for further cash, with participating investors also acquiring 4.3mn 5-year warrants with a strike price of $0.75. Although we acknowledge the potential dilution from the warrants, in our view it was necessary for DelMar to secure funding for its 2016E operating plan to ensure that it can continue to advance its lead product, VAL-083 into a registration-directed Phase II/III trial for the treatment of refractory GBM, the most deadly form of brain cancer. We are maintaining our 12 month price target of $4.53 per share,” commented Ajay Tandon, CEO of SeeThruEquity.

Additional highlights from the update note are as follows:

$2.6mn placement shores balance sheet

On August 20, 2015, DelMar announced that it had completed a $2.6mn registered direct placement. The move shores up the company’s balance sheet, which had $1.8mn in cash and no debt at the end of the June quarter. The placement consisted of 4.3mn shares priced at $0.60, and offers potential future funding in the form of 4.3mn warrants, which have a five-year term and a strike price of $0.75.

Proceeds to be used for registration-directed Phase II/III trial

DelMar management noted that the offering should provide the company with capital to help fund operations in 2016E, allowing DelMar to maintain its focus on advancing its lead product, VAL-083, into a registration-directed Phase II/III clinical trial for the treatment of GBM, the most common and deadly form of brain cancer. The move is consistent with the plans outlined by management to expand its cohort following the encouraging clinical data released earlier this year from its ongoing Phase I/II trial, which suggested that VAL-083 may be highly efficacious against both stem and non-stem GBM cell cultures.

Expansion of Non-dilutive funding from NRC-IRAP

The completion of the $2.6mn direct placement followed positive news announced on August 13, 2015, that DelMar had received an increase in funding of up to CDN$287,000 from the National Research Council of Canada Industrial Research Assistance Program (NRC-IRAP). The funding is non-dilutive for DelMar, and is intended to support and expands an ongoing project studying potential applications of VAL-083 in other cancerous tumor types beyond its current Phase I/II refractory GBM clinical trial into non-small cell lung cancer (NSCLC) and other solid tumors. We see the announcement as a positive step for DelMar and note that it brings total funding from NRC-IRAP to CDN$420,000 – following earlier funding used in collaboration with University of British Columbia, the Vancouver Prostate Center, and the B.C. Cancer Agency.

DelMar to investigate VAL-083 as treatment for ovarian cancer

This week DelMar announced that it was expanding the potential treatment areas of VAL-083 to include ovarian cancer. The company has conducted new research with researchers at MD Anderson, and expects to present its findings at American Association for Cancer Research’s October conference: Advances in Ovarian Cancer Research: Exploiting Vulnerabilities.

Please review important disclosures at www.seethruequity.com.

About DelMar Pharmaceuticals, Inc.

DelMar Pharmaceuticals was founded in 2010 to develop and commercialize proven cancer therapies in new orphan drug indications where patients are failing modern targeted or biologic treatments. The Company’s lead asset, VAL-083, is currently undergoing clinical trials in the United States as a potential treatment for refractory glioblastoma multiforme (GBM), the most common and aggressive form of brain cancer. VAL-083 benefits from extensive clinical research sponsored by the U.S. National Cancer Institute (NCI), and is currently approved for the treatment of chronic myelogenous leukemia (CML) and lung cancer in China. Published pre-clinical and clinical data suggest that VAL-083 may be active against a range of tumor types via a novel mechanism of action. For more information, please visit http://www.delmarpharma.com.

About SeeThruEquity

SeeThruEquity is an equity research and corporate access firm focused on companies with less than $1 billion in market capitalization. The research is not paid for and is unbiased. The company does not conduct any investment banking or commission based business. SeeThruEquity is approved to contribute its research to Thomson One Analytics (First Call), Capital IQ, FactSet, Zacks, and distribute its research to its database of opt-in investors. The company also contributes its estimates to Thomson Estimates, the leading estimates platform on Wall Street.

For more information visit www.seethruequity.com.

Contact:

Ajay Tandon
SeeThruEquity
info@seethruequity.com

SOURCE: SeeThruEquity

ReleaseID: 432102

CLS Holdings USA Provides Updated Investor Information on its Website

Please Visit http://www.clsholdingsinc.com – Click Investor Info Tab

BOULDER, CO / ACCESSWIRE / September 21, 2015 / CLS Holdings USA, Inc. (OTCQB: CLSH), a diversified cannabis company, has posted updated investor information on its website, http://www.clsholdingsinc.com. An updated Investor Powerpoint Presentation and Executive Summary have been added to its Investors Tab, at http://www.clsholdingsinc.com/corporate-info/.

Jeff Binder, Chairman, President and Chief Executive Officer of CLS Holdings USA, stated, “As we enter the final few months of 2015, we are pleased with our progress thus far in 2015 and even more excited about our prospects going into 2016. We look forward to further proving our extraction method and conversion process from testing in conjunction with two Colorado growers to live commercial operations with our licensee partner. In our continued efforts to communicate and be as transparent as possible with shareholders and the Wall Street community, we have and will continue to provide updated information on our website and through press releases.”

CLS stands for “Cannabis Life Sciences”, as it maintains a proprietary method of extracting various cannabinoids from the marijuana plant and converting them into higher quality and quantity. The Company mission is to be the industry leader in the extraction, conversion and marketing of cannabinoid oils, wax, edibles and shatter by leveraging our extraction methods and conversion processes.

About CLS Holdings USA, Inc.

CLS Holdings USA, Inc. is a diversified cannabis company, specializing in the extraction and conversion of cannabinoids. CLS stands for “Cannabis Life Sciences”, as it maintains a proprietary method of extracting various cannabinoids from the marijuana plant and converting them into higher quality and quantity. CLS Holdings USA business model includes licensing operations, processing revenue, processing facilities, sale of products and brand creation and consulting services.

For more information, check out: http://www.clsholdingsinc.com

Forward-Looking Statements

Forward-Looking Statements. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) (which Sections were adopted as part of the Private Securities Litigation Reform Act of 1995). Statements preceded by, followed by or that otherwise include the words “believe,” “anticipate,” “estimate,” “expect,” “intend,” “plan,” “project,” “prospects,” “outlook,” and similar words or expressions, or future or conditional verbs such as “will,” “should,” “would,” “may,” and “could” are generally forward-looking in nature and not historical facts. These forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company’s actual results, performance or achievements to be materially different from any anticipated results, performance or achievements. The Company disclaims any intention to, and undertakes no obligation to, revise any forward-looking statements, whether as a result of new information, a future event, or otherwise. For additional risks and uncertainties that could impact the Company’s forward-looking statements, please see the Company’s Form 8-K filed on April 30, 2015, including but not limited to the discussion under “Risk Factors” therein, which the Company has filed with the SEC and which may be viewed at http://www.sec.gov.

Contact:

Corporate:
Chairman and CEO
Jeff Binder
jeff@clsholdingsinc.com
888-438-9132

Investors:
Darrow Associates, Inc.
Peter Seltzberg, Managing Director
pseltzberg@darrowir.com
516-510-8768

SOURCE: CLS Holdings USA, Inc.

ReleaseID: 432098

Carmarthen Business Launches Their First 1965 Birthday DVD CD Card Set

Herbys Gifts releases Three previously unpublished facts about its upcoming 1965 Birthday DVD CD Card Set launch. Further information can be found at http://herbysgifts.com/.

Carmarthen, United Kingdom – September 21, 2015 /PressCable/

Ahead of the launch of its new new 1965 Birthday Cards Gift Package, Herbys Gifts is making public three as yet unreleased facts about 1965 Birthday DVD CD Cards Package set to go live 21st September, which fans and consumers within the Year Gifts and Greetings Cards space will find interesting…

The Three items include nuggets such as how:

The idea for creating 1965 Birthday DVD CD Card Set came about after receiving feedback from customers who bought the 1965 music cd card. They wanted to know if there were other 1965 gifts that could recommend. It then suddenly struck home that the 1965 DVD card would make an attractive package if added together in a single offering.

The 1965 Birthday DVD CD Cards Set has been in development for six months. As a result it was decided to find a cost effective way of presenting both items. A decision was made to contact a few packaging companies and sought ideas. A few months later the designer proposed a simple white cardboard design that would keep shipping costs low and enable the buyer to add a personal message to the outside of the folder. The development team was made up of two key people working closely together. As a small business in comparison to its competitors the development team regularly kept in contact to achieve the desired result by industry standards. This goes to show that by setting clear objectives , keeping in regular contact and carrying out testing that amazing things can be achieved within budget.

The new 1965 Birthday Cards Gift Package almost didn’t see the light of day, when the project was almost shelved following the production of first two packaging items both of which which failed miserably when put to the test. The first did not stand up to the presentation standards set and the second proved too flimsy when actually sent in the post. The problem was overcome by carrying out a complete re-design to overcome these specifics. After a number of telephone calls a conclusion was reached that the best way forward was to create a flat folder design which would be more presentable , be light to post and enable the buyer to clearly write engaging birthday messages on the cover.

The 1965 Birthday DVD CD Card Set will be released as part of Herbys Gifts’s greater plans to become the first choice on-line destination for consumers who are searching for year greetings cards. It’s hoped this goal will be achieved within the next 3 years

Herbys Gifts got it’s start when founders Nigel & Helen Herbert noticed a growing need for such a gift set and a package was put together in response to requests from its existing customers. The founder had 10 years experience in the year greetings card niche before establishing the business.

To connect with its customers Herbys Gifts use a regular newsletter , email marketing and social media and releasing these little factoids ahead of the 1965 Birthday DVD CD Card Set launch will make a difference.

The 1965 Birthday DVD CD Card Set is set to launch 21st September. To find out more, it’s possible to visit http://herbysgifts.com/products/1965-birthday-cards-gift-set-1965-dvd-1965-cd-and-1965-greetings-card

For more facts and further information about Herbys Gifts, this can be discovered at http://herbysgifts.com/

For more information about us, please visit http://herbysgifts.com/

Contact Info:
Name: Nigel Herbert
Organization: Herbys Gifts Ltd
Address: 27 LON Y PLAS
Phone: +44 (0) 1267 223973

Release ID: 91463

Hike the Park for Parkinson’s Returns to Oregon Ridge Park for the 6th Year

Springfield, VA, 09/19/2015 /SubmitPressRelease123/

For 10 years her father has been battling Parkinson’s Disease. For seven years, Stacey Mann has been on a mission to help her father and over one million Americans conquer this chronic, debilitating neurological disease. By founding the non-profit organization, Promises for Parkinson’s, Mrs. Mann has been able to create an annual event like no other. Hike the Park for Parkinson’s, with it’s steep climb up the Oregon Ridge ski slope and flat 3K walk, has Parkinson’s Patients, Care-Givers, their family and friends excited for fall. Raising over $62,000 in the last five years for University of Maryland School of Medicine’s Parkinson’s Disease and Movement Disorder Center, the fun family atmosphere of Hike the Park for Parkinson’s is worth your time.

The 6th Annual Hike the Park for Parkinson’s takes place on Saturday October 3, 2015, from 8-12 pm, at Oregon Ridge Park in Hunt Valley, Maryland. It will spread awareness for Parkinson’s and engage people from the Mid-Atlantic area to fight for those living with the disease. Dr. Lisa Shulman, Director of the Parkinson’s Disease and Movement Disorder Center at University of Maryland, will speak at the Hike. The fundraising goal of the hike is set at $30,000. All funds raised support the study of exercise and Parkinson’s Disease being conducted at the Center.

Parkinson’s disease is the second-most common neurodegenerative disease in the United States, afflicting 1 out of every 100 people. Although no two people are affected in the same way, symptoms include involuntary shaking, extreme muscle rigidity, dysfunction and slowness in limb movement and extremely impaired balance. With proper treatment, the symptoms can be controlled, though medication can eventually lose effectiveness, leaving the afflicted person unable to move, speak or swallow.

“Almost ten years ago, my father was diagnosed with Parkinson’s, and I was inspired by his strength and courage to get involved. While science works on a cure, we want to help improve the daily lives of Parkinson’s patients.“ says Stacey Mann, Executive Director of Promises for Parkinson’s. Established in 2009, Promises for Parkinson’s aims to create awareness of the disease and create fundraising opportunities such as Hike the Park to help support the cause. Promises for Parkinson’s is a completely volunteer based organization and is therefore able to donate 90% of every dollar raised directly to Parkinson’s research.

“The hike allows anyone, regardless of hiking ability, to get involved and make a difference in the lives of those living with Parkinson’s disease.” Registration is ongoing and sponsorship opportunities are available. The event includes a 5K Hike, 5K Trail Run, 3K Fun Run/Walk and a Paved Loop Walk for those using walkers or wheelchairs.

For those interested in participating, information about the hike and Parkinson’s disease is available by visiting www.promisesforparkinsons.org/hike or by calling the Promises for Parkinson’s office at 1.800.269.0624. Stacey Mann and her father are available for interviews.

News Provided By: Submit Press Release 123

Like Us on Facebook

Read the full story at http://newsreleases.submitpressrelease123.com/2015/09/21/hike-the-park-for-parkinsons-returns-to-oregon-ridge-park-for-the-6th-year/

ReleaseID: 16620

Continued Due Diligence Report

Can-Fite Biopharma Fast Track Designation Raises Prospects For Liver Cancer Treatment

NEW YORK, NY / ACCESSWIRE / September 21, 2015 / Shares of Can-Fite BioPharma Ltd. (NYSE-MKT: CANF) rallied 49% on Friday. The stock appears ready to build on last week’s gains following the FDA’s decision to grant Fast Track Designation to the company’s promising liver cancer treatment.

Broad Street Alerts continues its coverage of Can-Fite Biopharma that was initiated November 19, 2014 with a due diligence report that all shareholders will want to read.

A chartered financial analyst produces a due diligence report on CANF that includes an explanation of why this decision is so important for the company; along with a brief company overview, market overview, financial review, analyst summary, and recommendation. You can view this report by using the following link at no cost.

http://bit.ly/CANF_Due_Diligence_Report

About Broad Street Alerts:

We make the connection between sophisticated investors and high quality micro and small cap companies. An issuer of reports that provide a straightforward assessment of the profiled company. They include stocks traded in the NYSE, NASDAQ, and OTCBB exchanges.

Safe Harbor Statement:

This press release may include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements related to anticipated revenues, expenses, earnings, operating cash flows, the outlook for markets and the demand for products. Forward-looking statements are no guarantees of future performance and are inherently subject to uncertainties and other factors which could cause actual results to differ materially from the forward-looking statements. Such statements are based upon, among other things, assumptions made by, and information currently available to, management, including management’s own knowledge and assessment of the Company’s industry and competition. The Company refers interested persons to its most recent Annual Report on Form 10-K and its other SEC filings for a description of additional uncertainties and factors, which may affect forward-looking statements. The company assumes no duty to update its forward-looking statements

Compliance Procedure:

Content is researched, written and reviewed on a best-effort basis by a 3rd party chartered financial analyst. However, we are only human and may make mistakes. If you notice any errors or omissions, please notify us. This report was prepared for informational purposes only. A full disclaimer can be found by viewing the full analyst report. We do not hold any positions and have not been compensated in any form for this press release and coinciding reports. For more information and services provided beyond this press release please use contact information provided below.

CFA(R) and Chartered Financial Analyst(R) are registered trademarks owned by CFA Institute.

Contact:

editor@broadstreetalerts.com

SOURCE: Broad Street Alerts

ReleaseID: 432095

WeeCig Reports New Products Launched with Positive Results

NEW YORK, NY / ACCESSWIRE / September 21, 2015 / Wee-Cig International Corporation (OTC Pink: WCIG) reports that in the last several months the Company has launched two new vape products, the Wee-True and Wee-Vape as well as a silicon container sold to medical dispensaries called the Wee-Blockz.

Wee-True and Wee-Vape

The Wee-True comes only in black and has adjustable temperatures ranging from 200 to 428 degrees. The Wee-Vape also comes in black and has three temperature settings ranging from mild, medium and high temperatures. Both vape pens are fitted with a 2200 Mah battery and are quick to heat to the desired temperature. They are smokeless when activated and used, but users can still experience a smooth vape in terms of taste and feel. As the vape market grows, consumers look for more premium products which can deliver the same effective vape as conventional tabletop units, yet still be portable and stylish. Both the Wee-True and Wee-Vape are marketed as premium portable vaporizers, yet are available at the lower end price range of portable vaporizers appealing to all demographics.

Wee-Blockz

The Wee-Blockz is a non-stick shatter resistant block with a fun twist that makes it perfect for storing the desired concentrate without the oils, wax, or dabs sticking to the container wall. Furthermore the product is dishwasher safe, heat resistant and freezer safe making it perfect for reuse. The Wee-Blockz come in green, blue and red and can be used like Legos in color combinations to distinguish what’s inside. In addition, the Wee-Blockz is environmentally friendly doing away with plastic bags as well as being efficient, functional and stylish.

In addition to Wee-True, Wee-Vape, and Wee-Blockz, the Wee-Cig product line includes: the Wee-C, Wee-T, Wee-N, Wee-E, and Vapor Spirit. More information on all Wee-Cig products can be viewed at www.weecig.net.

“The launch of the Wee-True, Wee-Vape and Wee-Blockz enhances the current Wee-Cig product line which is different and fresh given how saturated and competitive the market is. Also, the United States has over 1,137,000 million registered medicinal patients, many of which use concentrate as opposed to regular herbs and this trend in usage continues to grow. The new Wee-Cig product line accommodates this special niche market”, states Matt Kelly, Director of Wee-Cig.

About Wee-Cig

Wee- Cig International is a technology company focused on being on the cutting edge of vaporization and electronic cigarettes. There are an estimated 1.2 billion smokers in the world and Wee-Cig looks to be a part of the movement of converting them to e-cig and vape users. Some of the Head and Vape Shops carrying the Wee-Cig Products are listed in the Company’s website www.weecig.net which get updated periodically.

More information on Wee-Cig product line and where you can purchase them can be found on www.weecig.net

For further information contact: 1-888-488-6882
/s/ Matt Kelly
Matt Kelly, Director

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements contained herein which are not historical fact are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, certain delays in testing and evaluation of products and other risks detailed from time to time in Wee-Cig’s filings with the OTC Markets.

SOURCE: Wee-Cig International Corporation

ReleaseID: 432105

Marijuanastocks.Com & FBEC Worldwide, Inc. To Host “Clear the Mud” Conference Call With Linda Strause, Phd, Tyler & Brendan Strause Of G. Randall & Sons Inc.

CORAL GABLES, FL / ACCESSWIRE / September 21, 2015 / MarijuanaStocks.com & FBEC Worldwide, Inc. (OTCQB: FBEC) are pleased to announce that it will host the “Clear The Mud” Conference Call, Wednesday September 23, 2015 at 4:15pm EST. The call will be led by Linda Strause, PhD, Tyler and Brendon Strause of G. Randall & Sons Inc. The conversation will focus on clarification and discussion of the environment, regulations, perspective, product development, and the benefits of hemp and hemp based products.

“We at G. Randall & Sons Inc. are committed to developing unique and effective products made from botanical hemp ingredients and to supporting education and research of cannabis, hemp, and the endocannabinoid system. We are excited to discuss The Wolfshot(TM), the first energy shot made with real hemp juice. Hemp Juice is a nutrient rich, cold pressed juice that’s low in fat, low in carbohydrates, a good source of vitamins and minerals, and a source of unique phytonutrients found only in hemp, cannabis.” said Linda Strause, PhD.

MarijuanaStocks.com and FBEC Worldwide, Inc. invites all those considering, to ask a question and attend the call, email the questions that you want answered to hempcall@marijuanastocks.com or message Marijuana Stocks on Facebook (https://www.facebook.com/pages/Marijuana-Stocks/221880533936?fref=ts) or Twitter (https://twitter.com/MarijuanaStocks).

The team at MarijuanaStocks.com and FBEC Worldwide, Inc. will do its best to ask every question received, within reason. You have until Wednesday September 23 at 4PM EST to submit your question(s) for the upcoming call.

To listen to the call live:

Dial-in Number: 712.775.7031
Meeting ID Number: 576-591-822

About MarijuanaStocks.com

MarijuanaStocks.com is the leading web destination for all things cannabis. Investors can find marijuana related financial, medical, legal, and social news anytime day or night. Writers are invited to submit cannabis related articles for publication.

About FBEC Worldwide, Inc.

FBEC Worldwide is an innovative beverage company dedicated to offering proprietary products focused towards significant target markets, both domestic and abroad. We are committed to increasing our market size and scope through the optics of creative marketing and most importantly customer satisfaction. Our growth strategies will focus on a number of major initiatives including, unique branding opportunities that will be targeted at key demographic groups, and to develop strong community and distributor relationships.

As we look ahead FBEC Worldwide will develop and build name brands focused on strong rates of growth within key fundamental consumer groups. Our company is dedicated to becoming a leading developer of name brand beverage alternatives geared specifically towards large, significantly important demographics within major markets.

Legal Disclaimer

Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. MAPH Enterprises LLC which owns www.MarijuanaStocks.com, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release.

MAPH Enterprises LLC, which owns www.MarijuanaStocks.com, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. MAPH Enterprises LLC, which owns www.MarijuanaStocks.com, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two.

Contact Information:

marijuanastocks.com
800-539-4313
pr@marijuanastocks.com

SOURCE: MarijuanaStocks.com

ReleaseID: 432103

TVIX Due Diligence Report: Fear is Growing, TVIX to Follow

NEW YORK, NY / ACCESSWIRE / September 21, 2015 / Credit Suisse Ag – VelocityShares Daily 2x VIX Short Term ETN (NASDAQ: TVIX) an exchange-traded note (ETN) tracking the CBOE Volatility Index (VIX) has certainly followed a rollercoaster path over the past month. With the Fed rate decision looming, the ETN experienced a massive upward move before falling just before the decision. Janet Yellen announced that the rate will remain unchanged and focused on the volatility in the Emerging Markets. This drove a small recovery in TVIX on Friday, moving the stock up 25%. There certainly may be more gains to come due to the upcoming economic calendar and instability in Global markets.

For a more detailed research report with analyst comments and recommendation on Credit Suisse Ag – VelocityShares Daily 2x VIX Short Term ETN please follow the link. There is no cost obligation required to view analyst brief.

http://bit.ly/_TVIX_Analyst_Report

About TVIX:

TVIX is an exchange-traded note (ETN), which is an unsecured debt obligation backed by Credit Suisse. Additionally, the ETN doesn’t have to hold actual VIX futures but is rather just a promise to pay the returns of a VIX futures index.

About Broad Street Alerts:

We make the connection between sophisticated investors and high quality micro and small cap companies. An issuer of reports that provide a straightforward assessment of the profiled company. They include stocks traded in the NYSE, NASDAQ, and OTCBB exchanges.

Safe Harbor Statement:

This press release may include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements related to anticipated revenues, expenses, earnings, operating cash flows, the outlook for markets and the demand for products. Forward-looking statements are no guarantees of future performance and are inherently subject to uncertainties and other factors which could cause actual results to differ materially from the forward-looking statements. Such statements are based upon, among other things, assumptions made by, and information currently available to, management, including management’s own knowledge and assessment of the Company’s industry and competition. The Company refers interested persons to its most recent Annual Report on Form 10-K and its other SEC filings for a description of additional uncertainties and factors, which may affect forward-looking statements. The company assumes no duty to update its forward-looking statements

Compliance Procedure:

Content is researched, written and reviewed on a best-effort basis by a 3rd party analyst. However, we are only human and may make mistakes. If you notice any errors or omissions, please notify us. This report was prepared for informational purposes only. A full disclaimer can be found by viewing the full analyst report. We do not hold any positions and have not been compensated in any form for this press release and coinciding reports. For more information and services provided beyond this press release please use contact information provided below.

Contact:

editor@broadstreetalerts.com

SOURCE: Broad Street Alerts

ReleaseID: 432096

‘Shrinking Piano’ Teaches Kids It Doesn’t Pay To Get Angry

NASHVILLE, TN – 21 Sep, 2015 – In this world of the alarming rise of disrespect and anger in kids, comes the arrival of the new children’s book, The Amazing Incredible Shrinking Piano as a helpful tool for parents as well as teachers. “The Amazing Incredible Shrinking Piano” is part of a series of illustrated books by Nashville, Tennessee author, Thornton Cline that instills in children important lessons of life. This book teaches how to control anger and teaches the respect of the piano-how to treat the piano kindly. Published by Centerstream/Hal Leonard Corporation, the book is illustrated by award-winning illustrator, Susan Oliver.

According to a recent Harris poll of 2,250 adults, respect for teachers dropped from 79% to a meager 31%.

“It is unfortunate that many kids today do not show respect to their teachers and to property. You can see that there are some serious anger issues in kids that teachers and parents must deal with,” says author Thornton Cline.

The Amazing Incredible Shrinking Piano is a wonderful teaching book that combines three books into one: text with illustrations for kids to read, a songbook of 10 original songs and a narrated audio book with children’s choir performances,” says Thornton Cline.

Cline’s first children’s book, The Amazing Incredible Shrinking Violin was an Amazon children’s bestseller in February of this year.

Thornton Cline has been honored with Songwriter of the Year twice in a row by the Tennessee Songwriters Association for his hit song, Love is The Reason recorded by Engelbert Humperdinck and Gloria Gaynor. He has received Dove and Grammy Award nominations for his songs. His articles have appeared in numerous national magazines, newspapers and journals. The Amazing Incredible Shrinking Piano is Cline’s sixth published book. He is author of The Contrary, Band of Angels, Practice Personalities, Practice Personalities for Adults, and The Amazing Incredible Shrinking Violin, on Centerstream/ Hal Leonard Corporation. Cline is an in-demand speaker for national conferences, book-signing events and workshops He lives in Nashville, Tennessee with his wife and two children.

Full News Story: https://pressreleasejet.com/newsreleases/2015/shrinking-piano-teaches-kids-it-doesnt-pay-to-get-angry/

Distributed by Press Release Jet

Media Contact
Company Name: Roaring Brook Productions
Contact Person: Susan Oliver
Email: Clinetel@bellsouth.net
Phone: 615-573-4880
Country: United States
Website: http://ThorntonCline.com

ReleaseID: 513733


Source: GetNews